Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 20353404)

1.

Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase.

Geyer BC, Kannan L, Cherni I, Woods RR, Soreq H, Mor TS.

Plant Biotechnol J. 2010 Oct;8(8):873-86. doi: 10.1111/j.1467-7652.2010.00515.x.

PMID:
20353404
2.

Gene-delivered butyrylcholinesterase is prophylactic against the toxicity of chemical warfare nerve agents and organophosphorus compounds.

Parikh K, Duysen EG, Snow B, Jensen NS, Manne V, Lockridge O, Chilukuri N.

J Pharmacol Exp Ther. 2011 Apr;337(1):92-101. doi: 10.1124/jpet.110.175646. Epub 2010 Dec 28.

3.

Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.

Wang Y, Boeck AT, Duysen EG, Van Keuren M, Saunders TL, Lockridge O.

Toxicol Appl Pharmacol. 2004 May 1;196(3):356-66.

PMID:
15094306
4.

Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure.

Brazzolotto X, Wandhammer M, Ronco C, Trovaslet M, Jean L, Lockridge O, Renard PY, Nachon F.

FEBS J. 2012 Aug;279(16):2905-16. doi: 10.1111/j.1742-4658.2012.08672.x. Epub 2012 Jul 12.

PMID:
22726956
5.

Bioscavengers for the protection of humans against organophosphate toxicity.

Doctor BP, Saxena A.

Chem Biol Interact. 2005 Dec 15;157-158:167-71. Epub 2005 Nov 15.

PMID:
16293236
6.

Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents.

Geyer BC, Kannan L, Garnaud PE, Broomfield CA, Cadieux CL, Cherni I, Hodgins SM, Kasten SA, Kelley K, Kilbourne J, Oliver ZP, Otto TC, Puffenberger I, Reeves TE, Robbins N 2nd, Woods RR, Soreq H, Lenz DE, Cerasoli DM, Mor TS.

Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20251-6. doi: 10.1073/pnas.1009021107. Epub 2010 Nov 8.

7.

Specificity of ethephon as a butyrylcholinesterase inhibitor and phosphorylating agent.

Haux JE, Lockridge O, Casida JE.

Chem Res Toxicol. 2002 Dec;15(12):1527-33.

PMID:
12482234
8.

Amino acid residues at the N- and C-termini are essential for the folding of active human butyrylcholinesterase polypeptide.

Naik RS, Pattabiraman N, Patel KA, Doctor BP, Saxena A.

Chem Biol Interact. 2013 Mar 25;203(1):24-9. doi: 10.1016/j.cbi.2012.09.018. Epub 2012 Oct 6.

PMID:
23044488
9.

Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization.

Nachon F, Nicolet Y, Viguié N, Masson P, Fontecilla-Camps JC, Lockridge O.

Eur J Biochem. 2002 Jan;269(2):630-7.

10.

Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model.

Rosenberg YJ, Saxena A, Sun W, Jiang X, Chilukuri N, Luo C, Doctor BP, Lee KD.

Chem Biol Interact. 2010 Sep 6;187(1-3):279-86. doi: 10.1016/j.cbi.2010.02.042. Epub 2010 Mar 6.

PMID:
20211615
11.

Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.

Primo-Parmo SL, Bartels CF, Wiersema B, van der Spek AF, Innis JW, La Du BN.

Am J Hum Genet. 1996 Jan;58(1):52-64.

12.

Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk.

Lockridge O, Masson P.

Neurotoxicology. 2000 Feb-Apr;21(1-2):113-26. Review.

PMID:
10794391
13.

Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers.

Li H, Schopfer LM, Masson P, Lockridge O.

Biochem J. 2008 Apr 15;411(2):425-32.

14.

Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.

Aurbek N, Thiermann H, Eyer F, Eyer P, Worek F.

Toxicology. 2009 May 17;259(3):133-9. doi: 10.1016/j.tox.2009.02.014. Epub 2009 Mar 6.

PMID:
19428953
15.

Acetylcholinesterase and butyrylcholinesterase expression in adult rabbit tissues and during development.

Jbilo O, L'Hermite Y, Talesa V, Toutant JP, Chatonnet A.

Eur J Biochem. 1994 Oct 1;225(1):115-24.

16.

Effect of polyethylene glycol modification on the circulatory stability and immunogenicity of recombinant human butyrylcholinesterase.

Chilukuri N, Sun W, Naik RS, Parikh K, Tang L, Doctor BP, Saxena A.

Chem Biol Interact. 2008 Sep 25;175(1-3):255-60. doi: 10.1016/j.cbi.2008.05.020. Epub 2008 May 21.

PMID:
18603232
17.

Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning.

Huang YJ, Huang Y, Baldassarre H, Wang B, Lazaris A, Leduc M, Bilodeau AS, Bellemare A, Côté M, Herskovits P, Touati M, Turcotte C, Valeanu L, Lemée N, Wilgus H, Bégin I, Bhatia B, Rao K, Neveu N, Brochu E, Pierson J, Hockley DK, Cerasoli DM, Lenz DE, Karatzas CN, Langermann S.

Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13603-8. Epub 2007 Jul 27.

18.
19.

Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase.

Kovarik Z, Katalinić M, Sinko G, Binder J, Holas O, Jung YS, Musilova L, Jun D, Kuca K.

Chem Biol Interact. 2010 Sep 6;187(1-3):167-71. doi: 10.1016/j.cbi.2010.02.023. Epub 2010 Mar 3.

PMID:
20206154
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk